Syntec Optics has launched the production of biomolecules and nanoparticles characterization optics used in direct light scattering instruments for biopharma technologists. Syntec’s new disposable optics enable fast measurements for low-volume requirements of proteins, viruses, gene therapy vectors, and more. Disposable optics require precise ports for the fluid flow of biomolecules and nanoparticles. Syntec Optics has many years of expertise delivering such intricate disposable optics for diagnostics, surgical instruments, and digital health imaging. Syntec will now expand its capability to provide dynamic light-scattering disposable optics.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPTX:
- Syntec Optics (Nasdaq: OPTX) Launches Production of New Disposable Optics for Characterization of Biomolecules and Nanoparticles
- Syntec Optics secures $2.2M in new orders for space optics
- Syntec Optics (Nasdaq: OPTX) Secures $2.2M in New Orders for Space Optics
- Syntec Optics (Nasdaq: OPTX) to Manufacture over $1M in Advanced Optics for Next Generation U.S. Defense Integrated Optics System
- Syntec Optics to manufacture over $1M in advanced optics
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue